CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 139 enrolled
Drug / intervention
Fisher & Paykel Healthcare CPAP Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02809859
NCT02809859N/ACompleted
CompareCT.gov

CPAP In-home Assessment USA

Fisher and Paykel Healthcare·interventional·Posted Jun 22, 2016·Updated Mar 5, 2019

In Brief

A clinical study evaluating Fisher & Paykel Healthcare CPAP Device for Obstructive Sleep Apnea. Completed, enrolled 139 participants across 4 sites.

Detailed Summary

The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 22, 2016
Enrollment StartJul 1, 2016
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.0 years ago

Interventions

Fisher & Paykel Healthcare CPAP Devicedevice

Fisher \& Paykel Healthcare CPAP Device